NBE-Therapeutics

NBE-Therapeutics

Latest funding
$22,000,000
Venture capital (Series C) - 2020
Boehringer Ingelheim Venture Fund PPF Group
Team Size
1–10
Employees
$22,000,000 Venture capital (Series C)
FinSMEs

NBE-Therapeutics Completes USD22M Series C Financing Round